The Ever-Changing Hard Surface Disinfectant Landscape in COVID-19 times

The Ever-Changing Hard Surface Disinfectant Landscape in COVID-19 times

Published on April 14, 2020

Author: Teri Dickinson, Manager, Regulatory Affairs, Dell Tech Laboratories Ltd.

These days, the world of hard surface disinfectants and pathway to registration changes almost weekly.  With the health and safety of Canadians being at the fore front the quick access to disinfectant products has been a top priority. 

Health Canada has implemented interim measures to expedite access to disinfectants to address product shortages and published a list of hard-surface disinfectants that are likely to be effective for use against coronavirus (COVID-19).

Want your product to be on the list?  Want to make indirect efficacy claims for SARS-CoV-2, the virus that causes COVID-19? Your product will need to be reviewed and approved with one or more of the following:

  • labelled as a broad-spectrum virucide, that is supported by an efficacy claim against any of:
    •    Adenovirus type 5
    •    Bovine Parovirus
    •    Canine Parvovirus
    •    Poliovirus type 1
  • carry a specific claim against non-enveloped viruses of the picornaviridae, caliciviridae, astroviridae, reoviridae, or papillomaviridae families or
  • carry a specific claim against a specific coronavirus, such as
    •    MERS-CoV
    •    SARS-CoV
    •    human coronavirus strain 229E

References:

Hard-surface disinfectants and hand sanitizers (COVID-19): List of hard-surface disinfectants 

https://www.canada.ca/en/health-canada/services/drugs-health-products/disinfectants/covid-19/list.html

 

 

Related Articles

Rare Diseases and Orphan Drugs Regulatory Framework in Canada: Recent Initiatives by Government of Canada

Rare Diseases and Orphan Drugs Regulatory Framework in Canada: Recent Initiatives by Government of Canada

What are Rare Diseases and How do They Affect Canadians? According to Health Canada, rare diseases are life-threatening, debilitating, or serious and chronic conditions that...

Health Canada changes filing requirements for product monographs

Health Canada changes filing requirements for product monographs

Did you know, effective immediately, Health Canada is changing the submission requirements for second language product monographs for human drugs? This is for only post-life...

Pragmatic Clinical Trials: Testing Treatments in the Real-World

Pragmatic Clinical Trials: Testing Treatments in the Real-World

What is a Pragmatic Clinical Trial? Clinical trials can be designed to be either pragmatic or explanatory. Explanatory trials are designed to find out whether a treatment...